Pharmaceuticals News
Press Releases from Pharmaceuticals Companies
Newsroom
Pharmaceuticals news releases from pharmaceuticals companies published by Newsfile. Searches will return results from stories up to two years old.
-
Lobe Sciences to Present at Psychedelic Capital Virtual Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - February 24, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at "The Gold...
Technology, Pharmaceuticals, Health
2021-02-24 5:00 PM ET | Lobe Sciences Ltd. -
Neovasc Regains Compliance with Nasdaq Minimum Market Value Rule
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 24, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") has received written notification (the "Nasdaq Notice") from the Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with the minimum market value requirement...
Pharmaceuticals, Health
2021-02-24 4:05 PM ET | Neovasc Inc. -
Tryp Therapeutics to Present at the Stifel GMP Healthcare Conference
La Jolla, California--(Newsfile Corp. - February 24, 2021) - Tryp Therapeutics (CSE: TRYP) ("Tryp" or the "Company") a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today the company has been invited to present at the Stifel GMP Healthcare Conference: Healthcare...
Biotechnology, Pharmaceuticals
2021-02-24 7:00 AM ET | Tryp Therapeutics Inc. -
Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications
Plantation, Florida--(Newsfile Corp. - February 23, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which
Pharmaceuticals, Health
2021-02-23 9:20 AM ET | Nutra Pharma Corporation -
Lobe Sciences Signs Definitive Agreement for Sale of Cowlitz Cannabis Assets to Ionic Brands Corp.
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") and Ionic Brands Corp. ("Ionic Brands") are pleased to announce that, further to their press releases dated December 1, 2020, Lobe's wholly owned subsidiary Green Star Biosciences Inc. has...
Technology, Pharmaceuticals, Health
2021-02-23 8:40 AM ET | Lobe Sciences Ltd. -
Accomplished Biophysicist Linnéa Olofsson, Ph.D. joins PreveCeutical
Vancouver, British Columbia--(Newsfile Corp. - February 23, 2021) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is very pleased to announce the appointment of Dr. Linnéa Olofsson as an advisor and consultant for the Company.Dr. Olofsson will be working with our team in implementing our strategies...
Biotechnology, Pharmaceuticals, Health
2021-02-23 8:00 AM ET | PreveCeutical Medical Inc. -
Innocan Pharma Announces the Completion of its First Full-Scale Manufacturing Run in the US and the Launching of its US Commercial Online Platform
Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - February 22, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the "Company" or "Innocan"), is pleased to announce the completion of its first full and large-scale commercial production of its SYNONY premium cosmetic line and Relief &Go OTC pain...
Pharmaceuticals, Cannabis, Cannabis Manufacturer, Cannabis Ancillary Service Provider
2021-02-22 4:00 PM ET | Innocan Pharma Corporation -
Lobe Sciences to Present at Virtual One2One Investor Forum
Vancouver, British Columbia--(Newsfile Corp. - February 22, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announces that Philip Young, CEO and Director, will be interviewed on Tuesday, February 23rd, 2021 at 1:00 pm EST by broadcast journalist Christine Corrado of Proactive Investors, a...
Technology, Pharmaceuticals, Health
2021-02-22 8:00 AM ET | Lobe Sciences Ltd. -
Minerco Announces the Global Launch of Their Crypto Blockchain Token SHRU for March 1st 2021
Kingston, Jamaica--(Newsfile Corp. - February 22, 2021) - On February 20th 2021, Minerco, Inc. (OTC PINK: MINE) hosted their SHROOM ZOOM meeting in which 800 out of the 1400 people who registered attended. During the meeting, ownership announced that their highly anticipated Crypto Blockchain Token SHRU is set to launch...
Pharmaceuticals, Psychedelics
2021-02-22 12:33 AM ET | Minerco, Inc. -
Minerco Inc., The Magic Mushroom Company, Addresses Speculative Rumors and Information Circulating Social Media Platforms
New York, New York--(Newsfile Corp. - February 19, 2021) - Minerco Inc. (OTC Pink: MINE) received numerous emails regarding alleged false information posted by bloggers in a failed-attempt to manipulate its stock by posting inaccurate research findings. Minerco's ownership team has spent over 12 months focusing its energy on creating...
Pharmaceuticals, Psychedelics
2021-02-19 12:10 AM ET | Minerco, Inc. -
Emerald Health Therapeutics to Close Greater Vancouver Production Facility
Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it will cease operations at its cannabis production facility in Greater Vancouver, British Columbia effective March 31, 2021 and will consider strategic alternatives for this facility. "Closing our Greater...
Pharmaceuticals, Cannabis, Health, Cannabis Manufacturer
2021-02-18 4:45 PM ET | Emerald Health Therapeutics, Inc. -
PAOG Expects To Realize Revenue This Year From New CBD Nutraceuticals
Sandusky, Ohio--(Newsfile Corp. - February 18, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the company's CBD nutraceutical development expansion plans. The presentation...
Pharmaceuticals, Cannabis, Cannabis Cultivator, Cannabis Ancillary Service Provider
2021-02-18 9:43 AM ET | PAO Group, Inc. -
Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device
Vancouver, British Columbia--(Newsfile Corp. - February 18, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) ("Lobe" or the "Company") announced today the completion and testing of the proof-of-concept prototype of its proprietary nasal mist device. As announced on December 3, 2020, the Company engaged VisionWorks Engineering of San Diego,...
Technology, Pharmaceuticals, Health
2021-02-18 8:30 AM ET | Lobe Sciences Ltd. -
Tryp Therapeutics Completes $2 Million Strategic Financing
La Jolla, California--(Newsfile Corp. - February 17, 2021) - Tryp Therapeutics Inc. (CSE: TRYP) ("Tryp"), a pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, is pleased to announce that effective February 16, 2021, it has closed its previously announced financing (see news...
Biotechnology, Pharmaceuticals
2021-02-17 5:38 PM ET | Tryp Therapeutics Inc. -
Neovasc to Participate in 10th Annual SVB Leerink Global Healthcare Conference
Vancouver, British Columbia--(Newsfile Corp. - February 17, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN), today announced that company management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference that is scheduled to take place from February 24 to 26, 2021. Fred Colen, Neovasc's President and Chief...
Pharmaceuticals, Health
2021-02-17 9:00 AM ET | Neovasc Inc. -
Canntab Engages Independent Trading Group for Market Making Services
Toronto, Ontario--(Newsfile Corp. - February 17, 2021) - Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FSE: TBF1) (the "Company" or "Canntab"), a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced today that it has engaged Independent Trading Group Inc. ("ITG") to provide market-making...
Pharmaceuticals, Cannabis, Health
2021-02-17 7:30 AM ET | Canntab Therapeutics Limited -
Nextleaf Solutions Awarded Cannabis Extraction Patent in Israel
Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) ("Nextleaf", "OILS", or the "Company"), the world's most innovative cannabis processor, announced today the Israeli Patent Office has granted the Company a patent for its foundational process for producing low-cost cannabis distillate, Nextleaf's fifth...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Extractor
2021-02-16 9:15 AM ET | Nextleaf Solutions Ltd. -
PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation
Sandusky, Ohio--(Newsfile Corp. - February 16, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today published an online, multimedia presentation detailing the Company's CBD nutraceutical development expansion plans. The CBD nutraceutical development expansion plans are anticipated to generate revenue beginning this year, in 2021 adding to the Company's...
Pharmaceuticals, Cannabis, Cannabis Cultivator, Cannabis Ancillary Service Provider
2021-02-16 8:58 AM ET | PAO Group, Inc. -
BioHarvest Sciences Inc. Announces Partnership with BOLDT and Summit Strategy Group to Develop a Sustainability Framework and ESG Report
Vancouver, British Columbia--(Newsfile Corp. - February 16, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) ("BioHarvest" or the "Company") announces that it has entered into a partnership with BOLDT AG, an international business strategy and communications consultancy based in Europe, and Summit Strategy Group LLC, a U.S.-based communications firm, to develop...
Biotechnology, Pharmaceuticals, Cannabis, Cannabis Cultivator
2021-02-16 8:55 AM ET | BioHarvest Sciences Inc. -
Minerco Inc., The Magic Mushroom Company, Paid Off Old Debt to Creditor EROP Capital
Atlanta, Georgia--(Newsfile Corp. - February 16, 2021) - Minerco Inc. (OTC Pink: MINE) inherited EROP Capital's debt that had been accrued from previous ownership. As a result, Minerco's new management team met with EROP Capital and completed debt settlement. In the aftermath of settling EROP's debt, Minerco's management also...
Pharmaceuticals, Psychedelics
2021-02-16 6:06 AM ET | Minerco, Inc.